No profile data available.
Nordicus Partners Corporation (NORD) is a financial services company in the alternative investment firms industry, based in Beverly Hills, United States.
It reported revenue of $0 for fiscal year 2026, down 100.0% from fiscal year 2025, and net income of -$4.00 million. Its market capitalization was $79.33 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended March 31, 2026; market data as of October 9, 2026.
Nordicus Partners Corporation, a biotech company specializing in developing breakthrough therapeutics for diseases with unmet medical needs in the United States. It develops medicines supporting oral health. The company was formerly known as EKIMAS Corporation and changed its name to Nordicus Partners Corporation in May 2023.
Nordicus Partners reported $0 in revenue for fiscal year 2026, down 100.0% from $5,000 in fiscal year 2025.
$79.33 million as of October 9, 2026.
Listed companies of a similar size in the same industry (alternative investment firms) include P10, Inc. (PX), Palisades Goldcorp Ltd. (PLGDF), DeFi Technologies Inc. (DEFT), KR1 Plc (KROEF).